Ryplazim
NDC 70573-099, plasminogen, injection, powder, lyophilized, for solution, from Kedrion Biopharma, Inc..
- Product NDC
- 70573-099
- Status
- Listed
- Labeler
- Kedrion Biopharma, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA125659
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70573-099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PLASMINOGEN68.8 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70573-099-02 | 70573009902 | 1 VIAL, GLASS in 1 CARTON (70573-099-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70573-099-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70573-099 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70573-099 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70573-099. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.